Showing session: reset
Tumor Heterogeneity, Clonal Evolution, and Therapeutic Response
- Sort by:
- Browse by:
- Permission not
granted for presentation
Tracking cancer evolution through therapy (TRACERx): Implications for immune targeting and surveillance
Charles Swanton
The Francis Crick Institute and UCL Cancer Institute, London, United Kingdom
- Free
- podium video
- slides video
- audio + slides
- All slides included
The AML genome(s)
Timothy J. Ley
Section of Stem Cell Biology, Division of Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, MO, United States
- Free
- podium video
- audio + slides
- Some slides withheld
Dissecting the complex ecosystem of malignant tumors with single cell RNA-Seq
Aviv Regev
Massachusetts Institute of Technology, Cambridge, MA, United States
- Permission not
granted for presentation
The evolution of cancer in response to targeted therapies
Jeffrey A. Engelman
Massachusetts General Hospital, Boston, MA, United States